The Harel Group
The Harel Group is a life science business advisory firm dedicated to supporting pharmaceutical, biotechnology, and medical device companies worldwide. Founded by Jacob Harel, the firm specializes in strategic business solutions including mergers and acquisitions, licensing, distribution, and strategic partnerships. With a global network and industry expertise, The Harel Group aims to facilitate international growth and innovation for its clients. The company also has a rich history of engaging in international collaborations, supporting business development initiatives, and participating in industry events, as evidenced by numerous photos from various global locations.
Industries
Nr. of Employees
small (1-50)
The Harel Group
Scotch Plains, New Jersey, United States, North America
Services
Advisory services covering target identification, transaction structuring, negotiation and execution to support M&A activity in life sciences.
Advisory and facilitation for licensing, co-promotion/co-marketing, joint ventures and distribution agreements to support commercialization.
Operational support including CRM upgrades, project management tool creation, reporting, and visual content/event documentation to enable business development execution.
Advisory and facilitation services for divestiture transactions including identification of buyers and transaction support.
Advisory services covering target identification, transaction structuring, negotiation and execution to support M&A activity in life sciences.
Advisory and facilitation for licensing, co-promotion/co-marketing, joint ventures and distribution agreements to support commercialization.
Operational support including CRM upgrades, project management tool creation, reporting, and visual content/event documentation to enable business development execution.
Advisory and facilitation services for divestiture transactions including identification of buyers and transaction support.
Expertise Areas
- Life sciences transaction advisory
- Mergers, acquisitions and divestitures
- Strategic licensing and commercial partnerships
- Regulatory strategy and regulatory operations
Key Technologies
- Customer relationship management (CRM) platforms
- Project management and workflow integration systems
- Financial modelling and forecasting tools
- Real-world evidence study methodologies
News & Updates
International Pharmaceutical News: OBS Group Completes 6th Acquisition in Pakistan
COOPER PHARMA and OSI Sign Distribution Agreement to protect and prevent against respiratory viruses including the one that causes COVID-19
Oral Science International engages The Harel Group to search for strategic partners globally.
Yama+ engages The Harel Group to search for strategic partners globally.
IceCure Medical engages The Harel Group to search for distributors in the US and Europe.
Biohope engages The Harel Group to search for strategic partners to commercialize Immunobiogram in Japan and Brazil.
International Pharmaceutical News: OBS Group Completes 6th Acquisition in Pakistan
COOPER PHARMA and OSI Sign Distribution Agreement to protect and prevent against respiratory viruses including the one that causes COVID-19
Oral Science International engages The Harel Group to search for strategic partners globally.
Yama+ engages The Harel Group to search for strategic partners globally.
IceCure Medical engages The Harel Group to search for distributors in the US and Europe.
Biohope engages The Harel Group to search for strategic partners to commercialize Immunobiogram in Japan and Brazil.